Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Michael Martin BreenExecutive Chairman/Interim CEO | GT BiopharmaGTBP | Open-market buy | 23/04/11 | 23/04/11 | 50,000 sh | $0.50 | $25,000 | +8.2% |
Manu OhriCFO & Secretary | GT BiopharmaGTBP | Open-market buy | 23/04/06 | 23/04/10 | 50,000 sh | $0.50 | $25,000 | No record |